For more than three decades, National Jewish Health Advanced Diagnostic Laboratories have provided contract research and clinical trial services to pharmaceutical, biotechnology and device manufacturers around the world.
Advanced Diagnostic Laboratories is well-known among the pharmaceutical, biotechnology and medical device communities for its extensive expertise in immunology and respiratory disease for personalized medicine. We provide end-to-end services for respiratory and immunologic diseases such as allergies, asthma, Cystic Fibrosis, COPD, GI, Lung & GI Cancers, Pulmonary Fibrosis, Interstitial Lung Disease, autoimmune diseases and immunodeficiencies.
As an international leader in respiratory and immunological medicine and research, National Jewish Health has extensive preclinical testing capabilities in areas such as complement activation, inhalation drug delivery and ozone exposure. Our CAP 15189 clinical laboratories perform safety and efficacy testing under non-GLP and GLP conditions.
View Study Test Menu
Custom Assay Design and Qualifications
Advanced Diagnostic Laboratories partners with diagnostic, pharmaceutical and biotechnology companies to translate biomarkers into Laboratory Developed Tests (LTDs) and in vitro diagnostic tests (IVD).
National Jewish Health Advanced Diagnostic Laboratories partner with diagnostic developers to translate research into diagnostic tests, laboratory-developed tests (LDTs), and in vitro diagnostic tests.